Podcasts > Archived Podcasts > Industry Focus
This show is no longer producing new episodes. Check out our other shows.
Industry Focus
Healthcare: Cann(‘t)Trust? And, What’s Behind Gilead’s Latest Mega-Deal
Jul 24, 2019 (25:50)
Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.